股市必读：北陆药业（300016）1月12日董秘有最新回复

Group 1 - The core stock price of Beilu Pharmaceutical (300016) closed at 9.44 yuan on January 12, 2026, with an increase of 2.39% and a turnover rate of 8.34%, resulting in a trading volume of 469,100 shares and a transaction amount of 439 million yuan [1] - The company reported significant revenue growth from its export products, primarily contrast agents and raw materials, covering markets in South America, Africa, and Asia [2] - The overall gross margin for the company's overseas business in 2024 was only 17.57%, significantly lower than the disclosed gross margin of 49.2% for contrast agents, attributed to a higher proportion of raw materials in the export revenue structure [2] Group 2 - On January 12, the net inflow of main funds into Beilu Pharmaceutical was 7.25 million yuan, indicating positive engagement from major investors [3] - The net inflow of speculative funds was 4.87 million yuan, while retail investors experienced a net outflow of 12.12 million yuan [4]